About Caspase-2
Caspase-2 (CASP2) is a protein
from Homo sapiens identified by UniProt accession
P42575, 452 residues long.
MolForge cross-references it against 0 known binders and
193 disease associations.
Target properties
| Protein name | Caspase-2 |
| UniProt accession | P42575 |
| Gene | CASP2 |
| Organism | Homo sapiens |
| Length | 452 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (193)
Diseases linked to this target (Open Targets).
- intellectual developmental disorder, autosomal recessive 80, with variant lissencephaly · score 0.63
- genetic disorder · score 0.49
- blood protein measurement · score 0.28
- breast adenocarcinoma · score 0.25
- head and neck squamous cell carcinoma · score 0.23
- lung adenocarcinoma · score 0.23
- gastric adenocarcinoma · score 0.23
- endometrial cancer · score 0.23
- cutaneous melanoma · score 0.13
- neoplasm · score 0.11
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P42575-F1 | alphafold | PREDICTED | 78.39 | — |
Amino-acid sequence (452 residues)
MAAPSAGSWS TFQHKELMAA DRGRRILGVC GMHPHHQETL KKNRVVLAKQ LLLSELLEHL LEKDIITLEM RELIQAKVGS FSQNVELLNL LPKRGPQAFD AFCEALRETK QGHLEDMLLT TLSGLQHVLP PLSCDYDLSL PFPVCESCPL YKKLRLSTDT VEHSLDNKDG PVCLQVKPCT PEFYQTHFQL AYRLQSRPRG LALVLSNVHF TGEKELEFRS GGDVDHSTLV TLFKLLGYDV HVLCDQTAQE MQEKLQNFAQ LPAHRVTDSC IVALLSHGVE GAIYGVDGKL LQLQEVFQLF DNANCPSLQN KPKMFFIQAC RGDETDRGVD QQDGKNHAGS PGCEESDAGK EKLPKMRLPT RSDMICGYAC LKGTAAMRNT KRGSWYIEAL AQVFSERACD MHVADMLVKV NALIKDREGY APGTEFHRCK EMSEYCSTLC RHLYLFPGHP PT
Explore Caspase-2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets